Results 141 to 150 of about 4,433,811 (160)
Aptamers and aptamer-drug conjugates as synthetic immune modulators for cancer immunotherapy. [PDF]
Arshad F +6 more
europepmc +1 more source
Aptamers are a group of synthetic single-stranded nucleic acids. They are generated from a random library of single-stranded DNA or RNA by a technology named systematic evolution of ligands by exponential enrichment (SELEX). SELEX is a repetitive process
Muhamad Aidilfitri Mohamad Roslan +2 more
exaly +2 more sources
Enhanced SELEX Platforms for Aptamer Selection With Improved Characteristics: A Review
Yildirim, Nimet/0000-0002-5973-8830This review delves into the advancements in molecular recognition through enhanced SELEX (Systematic Evolution of Ligands by Exponential Enrichment) platforms and post-aptamer modifications.
Nimet Yıldırım, Veli C Ozalp
exaly +2 more sources
Recent Advances in SELEX Technology and Aptamer Applications in Biomedicine
Aptamers are short DNA/RNA oligonucleotides capable of binding to target molecules with high affinity and specificity. The process of selecting an aptamer is called Systematic Evolution of Ligands by Exponential Enrichment (SELEX).
Jin Liu, Xiaohao Wu, Lü Aiping
exaly +2 more sources
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Capture-SELEX for Aptamer Selection: A Short Review
Talanta, 2021Zhouping Wang, Imran Mahmood Khan
exaly
SELEX: Critical Factors and Optimization Strategies for Successful Aptamer Selection
Biotechnology and Applied Biochemistry, 2022Gabriele Gadermaier
exaly
SELEX Modifications and Bioanalytical Techniques for Aptamer–Target Binding Characterization
Critical Reviews in Analytical Chemistry, 2016Clarence M Ongkudon +2 more
exaly

